The SCLC subtype expressing YAP1 is one of the most controversial, especially considering that a very recent publication revealed that most SCLC-Y tumour cell lines are SMARCA4 mutated, and demonstrating through a histopathological and molecular study that these tumours are strongly related to SMARCA4-deficient malignancies. This evidence concerns the gene SMARCA4 and neoplasm.